Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Jingjing Zhang"'
Autor:
Jie Zang, Yun Yang, Shaoming Chen, Chao Wang, Shaohao Chen, Shun Hu, Hai Cai, Xiaodong Li, Ning Xu, Xiaoyuan Chen, Jingjing Zhang, Weibing Miao
Publikováno v:
Journal of Nuclear Medicine; Aug2024, Vol. 65 Issue 8, p1-6, 6p
Autor:
Weizhi Xu, Jiayu Cai, Tianxing Peng, Tinghua Meng, Yizhen Pang, Long Sun, Hua Wu, Jingjing Zhang, Xiaoyuan Chen, Haojun Chen
Publikováno v:
Journal of Nuclear Medicine; Jan2024, Vol. 65 Issue 1, p40-51, 12p
Autor:
Guochang Wang, Jie Zang, Yuanyuan Jiang, Qingxing Liu, Huimin Sui, Rongxi Wang, Xinrong Fan, Jingjing Zhang, Zhaohui Zhu, Xiaoyuan Chen
Publikováno v:
Journal of Nuclear Medicine. 64:611-617
Autor:
Yizhen Pang, Liang Zhao, Tinghua Meng, Weizhi Xu, Qin Lin, Hua Wu, Jingjing Zhang, Xiaoyuan Chen, Long Sun, Haojun Chen
Publikováno v:
Journal of Nuclear Medicine. 64:386-394
Autor:
Liang Zhao, Xuejun Wen, Weizhi Xu, Yizhen Pang, Long Sun, Xiaoming Wu, Pengfei Xu, Jingjing Zhang, Zhide Guo, Qin Lin, Xiaoyuan Chen, Haojun Chen
Publikováno v:
Journal of Nuclear Medicine; Aug2023, Vol. 64 Issue 8, p1210-1217, 8p
Autor:
Frankis Almaguel, Franz C Robiller, Aviral Singh, Dirk Mueller, Christiane Smerling, Maythinee Chantadisai, Aleksandr Eismant, Christiane Schuchardt, Jingjing Zhang, Frank Osterkamp, Aileen Hoehne, Dirk Zboralski, Ulrich Reineke, Richard P. Baum, Harshad R. Kulkarni
Publikováno v:
Journal of Nuclear Medicine. 63:415-423
Fibroblast activation protein (FAP) is a promising target for diagnosis and therapy of numerous malignant tumors. FAP-2286 is the conjugate of a FAP-binding peptide, which can be labeled with radionuclides for theranostic applications. We present the
Autor:
Liang Zhao, Xuejun Wen, Weizhi Xu, Yizhen Pang, Long Sun, Xiaoming Wu, Pengfei Xu, Jingjing Zhang, Zhide Guo, Qin Lin, Xiaoyuan Chen, Haojun Chen
Publikováno v:
Journal of Nuclear Medicine. :jnumed.122.265383
Publikováno v:
J Nucl Med
The objective of this study was to assess the safety, dosimetry, and efficacy of the (177)Lu-labeled somatostatin receptor (SSTR) antagonist DOTA-p-Cl-Phe-cyclo(d-Cys-Tyr-d-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)d-Tyr-NH(2) ((177)Lu-DOTA-LM3) in patients
Autor:
Guochang Wang, Jie Zang, Yuanyuan Jiang, Qingxing Liu, Huimin Sui, Rongxi Wang, Xinrong Fan, Jingjing Zhang, Zhaohui Zhu, Xiaoyuan Chen
Publikováno v:
Journal of Nuclear Medicine; Apr2023, Vol. 64 Issue 4, p611-617, 7p
Autor:
Yizhen Pang, Liang Zhao, Tinghua Meng, Weizhi Xu, Qin Lin, Hua Wu, Jingjing Zhang, Xiaoyuan Chen, Long Sun, Haojun Chen
Publikováno v:
Journal of Nuclear Medicine; Mar2023, Vol. 64 Issue 3, p386-394, 9p